230 related articles for article (PubMed ID: 25915487)
1. Functional Genomics of Cardioprotection by Ischemic Conditioning and the Influence of Comorbid Conditions: Implications in Target Identification.
Varga ZV; Giricz Z; Bencsik P; Madonna R; Gyongyosi M; Schulz R; Mayr M; Thum T; Puskas LG; Ferdinandy P
Curr Drug Targets; 2015; 16(8):904-11. PubMed ID: 25915487
[TBL] [Abstract][Full Text] [Related]
2. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
[TBL] [Abstract][Full Text] [Related]
3. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
4. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.
Ferdinandy P; Hausenloy DJ; Heusch G; Baxter GF; Schulz R
Pharmacol Rev; 2014 Oct; 66(4):1142-74. PubMed ID: 25261534
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
Heusch G
Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology.
Madonna R; Cadeddu C; Deidda M; Giricz Z; Madeddu C; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Spallarossa P; Tocchetti CG; Varga ZV; Zito C; Geng YJ; Mercuro G; Ferdinandy P
Int J Cardiol; 2015 Jul; 191():203-10. PubMed ID: 25974196
[TBL] [Abstract][Full Text] [Related]
7. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
[TBL] [Abstract][Full Text] [Related]
8. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Andreadou I; Iliodromitis EK; Rassaf T; Schulz R; Papapetropoulos A; Ferdinandy P
Br J Pharmacol; 2015 Mar; 172(6):1587-606. PubMed ID: 24923364
[TBL] [Abstract][Full Text] [Related]
9. Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats.
Yang S; Abbott GW; Gao WD; Liu J; Luo C; Hu Z
J Appl Physiol (1985); 2017 May; 122(5):1095-1105. PubMed ID: 28153944
[TBL] [Abstract][Full Text] [Related]
10. Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.
Bencsik P; Gömöri K; Szabados T; Sántha P; Helyes Z; Jancsó G; Ferdinandy P; Görbe A
Br J Pharmacol; 2020 Dec; 177(23):5336-5356. PubMed ID: 32059259
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of non-coding RNAs and extracellular vesicles in cardioprotection by remote ischemic conditioning of the heart.
Bartekova M; Jelemensky M; Dhalla NS
Rev Cardiovasc Med; 2019 Jun; 20(2):59-71. PubMed ID: 31344998
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science).
Hausenloy DJ
Curr Pharm Des; 2013; 19(25):4544-63. PubMed ID: 23270554
[TBL] [Abstract][Full Text] [Related]
13. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
Heusch G; Rassaf T
Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.
Przyklenk K
Drugs Aging; 2011 May; 28(5):331-43. PubMed ID: 21542657
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs.
Varga ZV; Zvara A; Faragó N; Kocsis GF; Pipicz M; Gáspár R; Bencsik P; Görbe A; Csonka C; Puskás LG; Thum T; Csont T; Ferdinandy P
Am J Physiol Heart Circ Physiol; 2014 Jul; 307(2):H216-27. PubMed ID: 24858849
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
Andreadou I; Iliodromitis EK; Lazou A; Görbe A; Giricz Z; Schulz R; Ferdinandy P
Br J Pharmacol; 2017 Jun; 174(12):1555-1569. PubMed ID: 28060997
[TBL] [Abstract][Full Text] [Related]
17. Preconditioning and postconditioning: underlying mechanisms and clinical application.
Hausenloy DJ; Yellon DM
Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
[TBL] [Abstract][Full Text] [Related]
18. Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
Penna C; Granata R; Tocchetti CG; Gallo MP; Alloatti G; Pagliaro P
Curr Drug Targets; 2015; 16(8):843-67. PubMed ID: 25751010
[TBL] [Abstract][Full Text] [Related]
19. Perioperative Cardioprotection by Remote Ischemic Conditioning.
Cho YJ; Kim WH
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569468
[TBL] [Abstract][Full Text] [Related]
20. Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.
Miki T; Itoh T; Sunaga D; Miura T
Cardiovasc Diabetol; 2012 Jun; 11():67. PubMed ID: 22694800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
